Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model
Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an I...
Saved in:
Published in | Critical care medicine Vol. 23; no. 5; p. 901 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.1995
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an IL-1 receptor antagonist (IL-1ra) to investigate whether multiple organ failure due to acute pancreatitis is mediated by IL-1, as in other causes such as severe infection, trauma, and major surgery.
Prospective, randomized, controlled trial.
Research laboratory of a university medical school.
Specific pathogen-free male Wistar rats weighing 200 to 250 g.
Necrotizing pancreatitis was induced by retrograde injection of deoxycholate solution into the biliopancreatic duct. IL-1ra was injected intravenously at a dose of 10 mg/kg 15 mins before induction of acute pancreatitis and then infused continuously at a rate of 5 mg/kg/hr for the following 24 hrs.
Although treatment with recombinant human IL-1ra did not affect the degree of local pancreatic insult, it significantly reduced mortality, improved urine output as an indicator of the state of shock, and ameliorated the accumulation of neutrophils into the lung in a rat experimental pancreatitis model.
We concluded that multiple organ failure in severe pancreatitis is mediated, at least in part, by IL-1 through the activation of neutrophils. Furthermore, we concluded that circulatory collapse may also be important in the mechanism of the lethal effect of pancreatitis. |
---|---|
AbstractList | Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an IL-1 receptor antagonist (IL-1ra) to investigate whether multiple organ failure due to acute pancreatitis is mediated by IL-1, as in other causes such as severe infection, trauma, and major surgery.
Prospective, randomized, controlled trial.
Research laboratory of a university medical school.
Specific pathogen-free male Wistar rats weighing 200 to 250 g.
Necrotizing pancreatitis was induced by retrograde injection of deoxycholate solution into the biliopancreatic duct. IL-1ra was injected intravenously at a dose of 10 mg/kg 15 mins before induction of acute pancreatitis and then infused continuously at a rate of 5 mg/kg/hr for the following 24 hrs.
Although treatment with recombinant human IL-1ra did not affect the degree of local pancreatic insult, it significantly reduced mortality, improved urine output as an indicator of the state of shock, and ameliorated the accumulation of neutrophils into the lung in a rat experimental pancreatitis model.
We concluded that multiple organ failure in severe pancreatitis is mediated, at least in part, by IL-1 through the activation of neutrophils. Furthermore, we concluded that circulatory collapse may also be important in the mechanism of the lethal effect of pancreatitis. |
Author | Kato, T Matsuura, N Murata, A Mori, T Hayashida, H Uda, K Tanaka, N Toda, H |
Author_xml | – sequence: 1 givenname: N surname: Tanaka fullname: Tanaka, N organization: Department of Surgery II, Osaka University Medical School, Japan – sequence: 2 givenname: A surname: Murata fullname: Murata, A – sequence: 3 givenname: K surname: Uda fullname: Uda, K – sequence: 4 givenname: H surname: Toda fullname: Toda, H – sequence: 5 givenname: T surname: Kato fullname: Kato, T – sequence: 6 givenname: H surname: Hayashida fullname: Hayashida, H – sequence: 7 givenname: N surname: Matsuura fullname: Matsuura, N – sequence: 8 givenname: T surname: Mori fullname: Mori, T |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7736749$$D View this record in MEDLINE/PubMed |
BookMark | eNotUMtOwzAQ9KGotIVPQPIPGOzYqesjqnhUqsQFztXa3qSG1IkcB1G-gY8mha402pmVdnY1czKJbURCqOC3ght9x8eShVoyYUzJy1GxEcJMyIxzw5lURl6Sed-_j1NVajklU63lUiszIz-bmDE1OHyEyARN6LDLbaIQM9RtDH2mh9aHKmBP8x6p20OsRx4i_QwZGtqmGuJJ-8Ghp_ZIwQ0ZaUSX2hy-Q6xpB9ElhBxy-NsEmiBT_OowhQPGk814BJsrclFB0-P1uS_I2-PD6_qZbV-eNuv7LXOq5IZZqFCCkl7aVaVl4UqnVQW8lCsJTnjtLfAlOq8dGg0r4a3gytuiKgovuS8W5ObftxvsAf2uG9-AdNydUyl-AdD8ae4 |
CitedBy_id | crossref_primary_10_3109_00365521_2014_926983 crossref_primary_10_1016_j_freeradbiomed_2011_11_009 crossref_primary_10_1159_000070727 crossref_primary_10_15369_sujms1989_15_201 crossref_primary_10_1159_000018746 crossref_primary_10_1089_107999099313785 crossref_primary_10_1097_00003246_200108000_00010 crossref_primary_10_1097_00000658_200201000_00009 crossref_primary_10_3892_etm_2015_2270 crossref_primary_10_1016_S0039_6060_98_70106_0 crossref_primary_10_1111_j_1440_1746_1998_tb00600_x crossref_primary_10_3748_wjg_v9_i2_373 crossref_primary_10_1111_j_1939_1676_2012_00949_x crossref_primary_10_1080_13651820310001108 crossref_primary_10_1517_13543784_8_7_973 crossref_primary_10_1016_S0140_6736_03_13139_X crossref_primary_10_1159_000056106 crossref_primary_10_1080_003655201753265532 crossref_primary_10_1016_j_jamcollsurg_2005_10_010 crossref_primary_10_1517_14656566_4_2_235 crossref_primary_10_1097_01_shk_0000184285_57375_bc crossref_primary_10_1097_MPA_0000000000002343 crossref_primary_10_1177_17562848231202133 crossref_primary_10_1007_s11605_019_04411_w crossref_primary_10_1016_S0039_6109_05_70042_6 crossref_primary_10_1016_j_bcp_2014_12_016 crossref_primary_10_1016_S1091_255X_98_80109_1 crossref_primary_10_3748_wjg_v20_i45_16935 crossref_primary_10_1016_S0210_5691_03_79881_7 crossref_primary_10_3748_wjg_v20_i41_15200 crossref_primary_10_1164_rccm_2204019 crossref_primary_10_1016_S0039_6060_96_80296_0 crossref_primary_10_4292_wjgpt_v8_i1_10 crossref_primary_10_1089_jir_1997_17_113 crossref_primary_10_1159_000069148 crossref_primary_10_1016_S0016_5085_00_70271_X crossref_primary_10_1097_01_shk_0000191413_94461_b0 crossref_primary_10_1097_00000658_199806000_00004 crossref_primary_10_1053_j_gastro_2011_03_041 crossref_primary_10_1007_s11605_007_0175_2 crossref_primary_10_1097_01_CCM_0000081428_35729_73 crossref_primary_10_1016_j_biopha_2011_11_017 crossref_primary_10_1006_jsre_1997_5174 crossref_primary_10_1016_S1441_2772_23_00809_8 crossref_primary_10_1097_00003246_200007000_00064 crossref_primary_10_1016_S0002_9610_97_00240_7 crossref_primary_10_1016_j_biochi_2010_06_018 crossref_primary_10_1097_01_CCM_0000150661_69565_D8 crossref_primary_10_1111_j_1600_079X_2010_00808_x |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/00003246-199505000-00019 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 7736749 |
Genre | Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 1J1 354 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6J9 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYEP AAYOK ABASU ABBUW ABDIG ABJNI ABOCM ABPPZ ABVCZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFSOK AFUWQ AGINI AHOMT AHQNM AHRYX AHVBC AI. AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HLJTE HZ~ IE0 IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A NEJ NPM N~7 N~B N~M O9- OAG OAH OB4 OBH OCUKA ODA ODMTH ODZKP OHH OHT OHYEH OJAPA OL1 OLB OLG OLH OLU OLV OLW OLY OLZ ONV OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PKN PONUX R58 RIG RLZ S4R S4S T8P TEORI TSPGW V2I VH1 VVN W3M WOQ WOW X3V X3W X7M XXN XYM YCJ YFH YOC YOJ ZCG ZFV ZGI ZXP ZY1 ZZMQN ~9M |
ID | FETCH-LOGICAL-c4509-bafe3a43d3b8f732c5c74fa05383ac1d7dba06ecd7ce97a81db104db2f22d30d2 |
ISSN | 0090-3493 |
IngestDate | Wed Feb 19 02:35:55 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4509-bafe3a43d3b8f732c5c74fa05383ac1d7dba06ecd7ce97a81db104db2f22d30d2 |
PMID | 7736749 |
ParticipantIDs | pubmed_primary_7736749 |
PublicationCentury | 1900 |
PublicationDate | 1995-May |
PublicationDateYYYYMMDD | 1995-05-01 |
PublicationDate_xml | – month: 05 year: 1995 text: 1995-May |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Critical care medicine |
PublicationTitleAlternate | Crit Care Med |
PublicationYear | 1995 |
SSID | ssj0014573 |
Score | 1.7526121 |
Snippet | Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 901 |
SubjectTerms | Acute Disease Animals Deoxycholic Acid Disease Models, Animal Drug Evaluation, Preclinical Interleukin 1 Receptor Antagonist Protein Interleukin-1 - administration & dosage Male Multiple Organ Failure - drug therapy Multiple Organ Failure - etiology Necrosis Pancreas - pathology Pancreatitis - chemically induced Pancreatitis - complications Pancreatitis - drug therapy Prospective Studies Random Allocation Rats Rats, Wistar Receptors, Interleukin-1 - antagonists & inhibitors Receptors, Interleukin-1 - drug effects Recombinant Proteins - administration & dosage Sialoglycoproteins - administration & dosage Specific Pathogen-Free Organisms |
Title | Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7736749 |
Volume | 23 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTttAFB2FViA2VVtAQB-6i-6QkR8zHmdZVa0QEqwSiR2ap2QBJgsHiXwDX8DXcudhYqcgHhsr8WisZM7Jzbkz90HILylTKqWwiS6pSKhSRYJuRJ6YLJWMSsaNcrnDJ6fl0ZQen7Gz0ei-F7U0b-WhWjyZV_IeVPEe4uqyZN-A7OND8Qa-Rnzxigjj9VUY--28SzO_qJskO0DbZWatD4p0R02uJK5rdFPb2pVxQDqEJF8fAHvjeoWElk7uvZ6roESFcnEDDWrJ67Ze-Ex1pIUXlm3tZ4oD5MywMYDvptNXuY_9E3xc2erx_UQ04kIMjoEQbtGKwdbqVIvBLqyL91kmU-iYuMeWUYGd7R2jxaehH2Jne0OuceQY6xnScZj6n4EPhYPdvywqwdKFyaCEi9nxwfb2cJ9deeA5L0pOXx5cKbwdR9bIGnogrqWq2weK51OUxdiF-J1ijFhXDvSpz7ZJ1uMTVzwYr2Qmn8mn6ILA78CnL2Rkmq9k4ySitEXuBrSCjlawpBV0tAKkFURaQd2ApxUEWkGkFchb8LSCHq2gTys3UwAyAPq0Ak-rbTL993fy5yiJTTsSRVF8Jvi7N4WghS5kZXmRK6Y4tQJtfVUIlWmupUhLozRXZswFuksyS6mWuc1zXaQ63yEfmuvG7OKKVnwsU2uta1XPDJeZyihnXLMKJVZV7pGdsI7ns1CZ5Twu8P5zA9_I5pKa38lHi4bA_EBV2cqfHuAH3714hw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-1+receptor+antagonist+modifies+the+changes+in+vital+organs+induced+by+acute+necrotizing+pancreatitis+in+a+rat+experimental+model&rft.jtitle=Critical+care+medicine&rft.au=Tanaka%2C+N&rft.au=Murata%2C+A&rft.au=Uda%2C+K&rft.au=Toda%2C+H&rft.date=1995-05-01&rft.issn=0090-3493&rft.volume=23&rft.issue=5&rft.spage=901&rft_id=info:doi/10.1097%2F00003246-199505000-00019&rft_id=info%3Apmid%2F7736749&rft_id=info%3Apmid%2F7736749&rft.externalDocID=7736749 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-3493&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-3493&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-3493&client=summon |